Axelsen

Incubate Launches Policy Lab Under New Leadership and Releases IP White Paper

Retrieved on: 
星期五, 四月 26, 2024
Competition, Medication, World Intellectual Property Day, Policy, Climate, Intellectual property, Innovation, Axelsen, University, Patent, Patient, Incubation, Private sector, Drug development

In the coming months, Incubate Policy Lab -- the research arm of Incubate -- plans to release additional reports and white papers focused on issues at the intersection of policymaking, venture investment, and drug development.

Key Points: 
  • Accompanying the launch is a new white paper examining the important role intellectual property protections play in biopharmaceutical development.
  • "We launched Incubate Policy Lab to explore the various impacts policy decisions can have on innovation and investment in the life sciences industry," said Incubate executive director John Stanford.
  • In the coming months, Incubate Policy Lab -- the research arm of Incubate -- plans to release additional reports and white papers focused on issues at the intersection of policymaking, venture investment, and drug development.
  • "We're delighted to release this new white paper from Incubate Policy Lab," Axelsen said.